How should I conduct a risk assessment for a new medicine transport route?

Risk assessment of a new transport route is a key step in ensuring that medicines are adequately protected on a new, unvalidated route. The assessment should be systematic and documented: 1. **Define the route and products**: Specify the starting point, destination and key transit points, as well as the specific storage requirements of the medicines to be transported (such as room temperature or cold chain). 2. **Identify risk factors**: Brainstorm all risks that could affect medicine quality. These include transit time, climatic conditions in the regions along the route (extreme heat or cold), the likelihood of traffic delays, customs inspection procedures and duration, storage conditions at transit points, and security risks during transport. 3. **Assess risk levels**: For each identified risk, assess its probability of occurrence and the severity of its impact on medicine quality if it occurs. Combine the two to determine the level of each risk (high, medium or low). 4. **Establish control measures**: Develop specific control and mitigation measures for all medium- and high-level risks. For example, a validated passive cooler may be needed to address heat risk, while extra cool packs may be required in the packaging to mitigate delay risk. 5. **Validation and monitoring**: During the first commercial shipment or a simulated shipment, use temperature loggers to verify the effectiveness of the control measures.